These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26538644)

  • 1. microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain.
    Kim J; Yoon H; Horie T; Burchett JM; Restivo JL; Rotllan N; Ramírez CM; Verghese PB; Ihara M; Hoe HS; Esau C; Fernández-Hernando C; Holtzman DM; Cirrito JR; Ono K; Kim J
    J Neurosci; 2015 Nov; 35(44):14717-26. PubMed ID: 26538644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3.
    Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L
    Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
    Corona AW; Kodoma N; Casali BT; Landreth GE
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia.
    Chernick D; Ortiz-Valle S; Jeong A; Swaminathan SK; Kandimalla KK; Rebeck GW; Li L
    J Neurochem; 2018 Dec; 147(5):647-662. PubMed ID: 30028014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease.
    Wahrle SE; Jiang H; Parsadanian M; Hartman RE; Bales KR; Paul SM; Holtzman DM
    J Biol Chem; 2005 Dec; 280(52):43236-42. PubMed ID: 16207708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
    Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
    J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.
    Rawat V; Wang S; Sima J; Bar R; Liraz O; Gundimeda U; Parekh T; Chan J; Johansson JO; Tang C; Chui HC; Harrington MG; Michaelson DM; Yassine HN
    J Neurosci; 2019 Nov; 39(48):9611-9622. PubMed ID: 31641056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-binding cassette transporter A1: from metabolism to neurodegeneration.
    Koldamova R; Fitz NF; Lefterov I
    Neurobiol Dis; 2014 Dec; 72 Pt A():13-21. PubMed ID: 24844148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.
    Wahrle SE; Jiang H; Parsadanian M; Kim J; Li A; Knoten A; Jain S; Hirsch-Reinshagen V; Wellington CL; Bales KR; Paul SM; Holtzman DM
    J Clin Invest; 2008 Feb; 118(2):671-82. PubMed ID: 18202749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why lipids are important for Alzheimer disease?
    Hirsch-Reinshagen V; Burgess BL; Wellington CL
    Mol Cell Biochem; 2009 Jun; 326(1-2):121-9. PubMed ID: 19116777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
    Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J
    Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.
    Kim J; Yoon H; Ramírez CM; Lee SM; Hoe HS; Fernández-Hernando C; Kim J
    Exp Neurol; 2012 Jun; 235(2):476-83. PubMed ID: 22119192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Sirt2 Decreases ApoE Secretion in Astrocytes and Microglial Cells.
    Chen Y; Zhou C; Abdelhamid M; Jung CG; Michikawa M
    J Biochem; 2023 Oct; 174(5):409-420. PubMed ID: 37488092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
    Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
    Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice.
    Koldamova R; Staufenbiel M; Lefterov I
    J Biol Chem; 2005 Dec; 280(52):43224-35. PubMed ID: 16207713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.